维普中文期刊产品整合服务
21篇 您的检索式:作者名="Andrew Vickers"
    题名 作者 年代 出处 被引量
1Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study显示文摘William C Huang Andrew S Levey Angel M Serio Mark Snyder Andrew J Vickers Ganesh V Raj Peter T Scardino Paul Russo 2006Lancet Oncology2006,,9:4
2补充医学的最新进展显示文摘Andrew Vickers 宋军 2002英国医学杂志中文版2002,5,3:2
3Tumor markers in prostate cancer I: Blood-based markers显示文摘Shahrokh F. Shariat Axel Semjonow Hans Lilja Caroline Savage Andrew J. Vickers Anders Bjartell 2011Acta Oncologica2011,,1:1
4Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers显示文摘Andrew J Vickers Angel M 2008BMC medical informatics and decision making2008,,8:1
5Ac- upuncture-Point Stimulation for Chemotherapy-Induced Nausea andVomiting显示文摘Jeanette Ezzo Andrew Vickers Mary Ann Richardson 2005J ClinOneol2005,23,28:1
6Acupunc- ture for Postchemotherapy Fatigue: A Phase Ⅱ Study显示文摘Andrew J Vickers David J Straus Bertha Fearon 2004J Clin Oncol2004,22,9:1
7针灸治疗慢性头痛的初级保健:大样本、实用的随机试验显示文摘目的 与“不用针灸”对比,确定“使用针 灸”的治疗方法对慢性头痛患者的头痛、健康状 况及无病时间的影响。 设计 随机对照试验。 试验场所 英格兰和威尔士的开业医生诊所。 受试对象 401位慢性头痛患者,主要是偏 头痛患者。 干预 患者被随机分配进入针灸治疗组(在 3个月内接受12次针灸治疗)和对照组(接受常 规治疗)。 主要结果测定指标 治疗前、治疗后3个月 及12个月对头痛积分,SF-36健康状况及用药量 进行评估。每3个月对治疗方法作1次评估。头 痛积分即判定疗效的主要终点指标。 结果 针灸组治疗后12个月的头痛积分(针 灸组161例患者,平均头痛积分为16.2,标准差 13.7,比治疗前减少34%)比对照组低(对照组140 例患者,平均头痛积分为22.3,标准差17.0,比 治疗前减少16%)。两种方法调整后的差异为4.6 (95%可信区间为2.2-7.0;P=0.0002)。对于包 含缺失数据的灵敏度分析,该结果也是肯定的。 针灸组的患者每年少头痛22(8-38)天。尽管达到 统计学差异的项目仅有生理功能、精力和健康改 变等,SF-36的资料也有利于针灸组。与对照组相 比,针灸组的患者减少了15%的服药量(P=0.02), 减少了25%的就诊量(P=0.10),同时减少15%的 病休时间(P=0.2)。 结论 针灸在初级保健中用于治疗慢性头痛, 特别是偏头痛,可以产生与临床相关的持久益 处。应当考虑扩大英国国家医疗保险体系中针灸 治疗的范围。Andrew J Vickers Rebecca W Rees Catherine E Zollman Rob McCarney Claire Smith Nadia Ellis Peter Fisher Robbert Van Haselen 宋军 2005英国医学杂志中文版2005,8,2:1
8Using a remote sensing field experiment to investigate flux-footprint relations and flux sampling distributions for tower and aircraft-based observations显示文摘William P. Kustas Martha C. Anderson Andrew N. French Dean Vickers 2005Advances in Water Resources2005,,2:1
9Can acupuncture have spe- cific effects on health? A systematic review of acu- puncture antiemesis trials显示文摘Andrew J Vickers M A 1996J R Soc Med1996,89,6:1
10Predictive Value of Four Kallikrein Markers for Pathologically Insignificant Compared With Aggressive Prostate Cancer in Radical Prostatectomy Specimens: Results From the European Randomized Study of Screening for Prostate Cancer Section Rotterdam显示文摘Sigrid Carlsson Alexandra Maschino Fritz Schr?der Chris Bangma Ewout W. Steyerberg Theo van der Kwast Geert van Leenders Andrew Vickers Hans Lilja Monique J. Roobol 2013European Urology2013,,:1
11A phase I/II trial of a polysaccharide extract from Grifola frondosa (Maitake mushroom) in breast cancer patients: immunological effects显示文摘Gary Deng Hong Lin Andrew Seidman Monica Fornier Gabriella D'Andrea Kathleen Wesa Simon Yeung Susanna Cunningham-Rundles Andrew J. Vickers Barrie Cassileth Journal of Cancer Research and Clinical Oncology0,,:1
12Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: A Randomized Clinical Trial显示文摘Bernard H. Bochner Guido Dalbagni Daniel D. Sjoberg Jonathan Silberstein Gal E. Keren Paz S. Machele Donat Jonathan A. Coleman Sheila Mathew Andrew Vickers Geoffrey C. Schnorr Michael A. Feuerstein Bruce Rapkin Raul O. Parra Harry W. Herr Vincent P. Laudo 2014European Urology2014,,:1
13Temporary Renal Ischemia During Nephron Sparing Surgery is Associated With Short-Term but Not Long-Term Impairment in Renal Function显示文摘Ofer Yossepowitch Scott E. Eggener Angel Serio William C. Huang Mark E. Snyder Andrew J. Vickers Paul Russo 2006The Journal of Urology2006,,:1
14Comprehensive Prospective Comparative Analysis of Outcomes Between Open and Laparoscopic Radical Prostatectomy Conducted in 2003 to 2005显示文摘Karim Touijer James A. Eastham Fernando P. Secin Javier Romero Otero Angel Serio Jason Stasi Rafael Sanchez-Salas Andrew Vickers Victor E. Reuter Peter T. Scardino Bertrand Guillonneau 2008The Journal of Urology2008,,5:1
15Online education:Targeted MOOC captivates students显示文摘Carolyn King Andrew Robinson James Vickers 2014Nature2014,505,7481:1
16Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study显示文摘William C Huang Andrew S Levey Angel M Serio Mark Snyder Andrew J Vickers Ganesh V Raj Peter T Scardino Paul Russo 2006Lancet Oncology2006,,9:1
17Recent advances complementary medi- cine显示文摘Andrew Vickers 2002BMJ2002,5,3:1
18A phase I/II trial of a polysaccharide extract from Grifola frondosa (Maitake mushroom) in breast cancer patients: immunological effects显示文摘Gary Deng Hong Lin Andrew Seidman Monica Fornier Gabriella D’Andrea Kathleen Wesa Simon Yeung Susanna Cunningham-Rundles Andrew J. Vickers Barrie Cassileth 2009Journal of Cancer Research and Clinical Oncology2009,,9:1
19Contemporary Use of Partial Nephrectomy at a Tertiary Care Center in the United States显示文摘R. Houston Thompson Matt Kaag Andrew Vickers Shilajit Kundu Melanie Bernstein William Lowrance David Galvin Guido Dalbagni Karim Touijer Paul Russo 2009The Journal of Urology2009,,3:1
20Neuromyelitis optica and myelin oligodendrocyte glycoprotein显示文摘Neuromyelitis optica(NMO)refers to an antibody mediated,inflammatory disorder of the central nervous system(CNS)characterized by recurrent or monophasic attacks of optic neuritis and myelitis.Most patients with NMO possess a specific serum immunoglobin,NMO-IgG,which can serve as a biomarker for NMO.The autoantibodies target aquaporin-4(AQP4),the main water channel protein found in the CNS including the brain,spinal cord,and optic nerve.The remaining 10-25%of patients are seronegative for NMO-IgG despite meeting the diagnostic criteria for NMO.Recent studies have shown that a subset of these patients is seropositive for antibodies against myelin oligodendrocyte glycoprotein(MOG).This paper will provide an overview of the current English scientific literature published regarding the history,epidemiology,AQP4 biomarker,MOG biomarker,diagnosis,clinical features,related diseases in NMO spectrum disorder(NMOSD),and treatments of NMO.Angela Huang Aroucha Vickers Claudia M.Prospero Ponce Andrew G.Lee 2018Annals of Eye Science2018,,1:0
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费